Jpmorgan Chase & CO Immunocore Holdings PLC Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
152Shares Held
39.8MCall Options Held
157KPut Options Held
139K-
Wellington Management Group LLP Boston, MA6.38MShares$199 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$152 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$93.3 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.3 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$60.8 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.37B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...